08759359 is referenced by 14 patents and cites 256 patents.

The present invention provides fused derivatives of Formula I: that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Title
Substituted heteroaryl fused derivatives as PI3K inhibitors
Application Number
12/971863
Publication Number
8759359 (B2)
Application Date
December 17, 2010
Publication Date
June 24, 2014
Inventor
Richard B Sparks
Boothwyn
PA, US
Eddy W Yue
Landenberg
PA, US
Yun Long Li
Chadds Ford
PA, US
Andrew P Combs
Kennett Square
PA, US
Agent
Fish & Richardson P C
Assignee
Incyte Corporation
DE, US
IPC
A61P 35/00
A61P 17/06
A61P 27/02
A61P 9/10
A61P 9/00
A61P 19/08
A61P 19/02
C12N 9/99
C07D 513/04
C07D 473/34
C07D 519/00
A61K 31/52
View Original Source